Wilson Marc 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Jul 17, 2024
Insider Transaction Report
Form 4
Wilson Marc
CFO
Transactions
- Exercise/Conversion
Common Stock
2024-07-15$20.02/sh+25,000$500,500→ 136,092 total - Exercise/Conversion
Stock option (Right to Buy)
2024-07-15−25,000→ 66,000 totalExercise: $20.02Exp: 2032-02-29→ Common Stock (25,000 underlying) - Sale
Common Stock
2024-07-15$55.00/sh−25,000$1,375,000→ 111,092 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]1/48th of the shares subject to the option vested on March 31, 2022, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.